Health and Fitness Health and Fitness
Wed, March 13, 2013
Tue, March 12, 2013
Mon, March 11, 2013
Sun, March 10, 2013
Sat, March 9, 2013
Fri, March 8, 2013
Thu, March 7, 2013
Wed, March 6, 2013
[ Wed, Mar 06th 2013 ] - Market Wire
Alchemia Granted Key US Patent
Tue, March 5, 2013
Mon, March 4, 2013
Sun, March 3, 2013
Sat, March 2, 2013
Fri, March 1, 2013
Thu, February 28, 2013
Wed, February 27, 2013
Tue, February 26, 2013
Mon, February 25, 2013
Sun, February 24, 2013
Sat, February 23, 2013
Fri, February 22, 2013
Thu, February 21, 2013
[ Thu, Feb 21st 2013 ] - Market Wire
Inorganic Growth of Healthcare
Wed, February 20, 2013
Tue, February 19, 2013

AVANIR Pharmaceuticals To paticipate in two conferences in March


//health-fitness.news-articles.net/content/2013/ .. s-to-paticipate-in-two-conferences-in-march.html
Published in Health and Fitness on Friday, March 1st 2013 at 6:15 GMT by Market Wire   Print publication without navigation


AVANIR Pharmaceuticals To paticipate in two conferences in March -- ALISO VIEJO, Calif., March 1, 2013 /PRNewswire/ --

ALISO VIEJO, Calif., March 1, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: [ AVNR ]) today announced that company management will present an overview of the company at the following conferences in March.

(Logo: [ http://photos.prnewswire.com/prnh/20130207/LA55901LOGO ])

  • Cowen & Company 33rd Annual Healthcare Conference
    • Location: Boston Marriott Copley Place, Boston, MA
    • Presentation date: Tuesday March 5, 2013
    • Presentation time: 9:20 a.m. E.T.
  • 25th Annual ROTH Conference
    • Location: Ritz-Carlton, Laguna Niguel, CA
    • Presentation date: Wednesday March 20, 2013
    • Presentation time: 11:30 a.m. P.T.

A live webcast and 30-day archive of these presentations will be available at [ http://ir.avanir.com ].

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit [ www.avanir.com ].

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements , PhD
[ ir@avanir.com ]
+1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.



RELATED LINKS
[ www.avanir.com ]

Publication Contributing Sources